Pulmonary Vascular Research Institute (PVRI) is a global medical organisation focused on the improvement of care and awareness of pulmonary vascular diseases.
The PVRI is delighted to welcome Anna Hemnes to the Pulmonary Circulation journal editorial board, as one of our two Editors in Chief. Read more:
#PulmonaryCirculation
#PCJournal
#Journal
Congratulations to Dr Raymond Benza on his appointment as Chief of Pulmonary Hypertension for the Mount Sinai Health System. Ray has been a longstanding member, leader and friend of the PVRI for many years, so we are thrilled so celebrate this news:
We are delighted to announce that our next Congress will be held in London from 31 January to 3 February 2024. More details about the programme will follow soon
#PVRI2024
Following a successful Presidency in the hands of Dr Kurt Stenmark, we are very proud to welcome Dr Anna Hemnes as our new President from the 3 February 2024.
Yesterday we hosted an inspiring Women in PH Luncheon with United Therapeutics Corporation. Nicole deFreese and Anna Hemnes welcomed women from around the world who shared their journeys and what it means to them to be a woman in
#PulmonaryHypertension
Today is
#WorldPHDay2023
. In recognising and celebrating World PH Day, the PVRI wishes to emphasise its commitment to improving the lives of patients across the globe who suffer from this serious life-threatening condition:
Registration for PVRI 2024 Annual Congress London is now open. Don't miss out on this opportunity to connect and collaborate with the best minds in
#PulmonaryHypertension
. Register now:
#PVRI2024
#OvertoYou
Welcome to
#PVRI2024
London! We're so excited to welcome our delegates to our home city of London. It is not only PVRI’s home but also its birthplace. Just a short drive away from our 2024 Congress venue, PVRI’s journey began 18 years ago.
Thanks for coming. PVRI2022 Athens was attended by over 350 people from around the world and we couldn’t have been more pleased to see you again. Thanks to those who attended for making the meeting such a special occasion. Read our meeting report here:
The PVRI is deeply saddened by the loss of Dr John Newman, a cherished member of the Pulmonary Vascular Disease community. His dedication and expertise have left an indelible mark on our field. Sending heartfelt condolences to his loved ones and colleagues during this time.
Great energy in the poster session this evening! Lots of interesting discussions and ideas highlighting research and discoveries which are contributing to the ongoing evolution of the field. Here’s some photos of the great work:
This
#WorldLungDay2023
, we are thrilled to announce the first Pulmonary Hypertension (PH) Global Patient Survey
#PHGPS
will launch on 16 October 2023. The survey will improve global understandings of how PH affects the lives of patients and how patient care can be improved. 🧵👇
Congratulations to Professor Paul A. Corris on being awarded an ERS Lifetime Achievement Award in recognition of a lifetime of excellence in the field of thoracic surgery and transplantation. Read more:
1/15 To celebrate world pulmonary hypertension week, we’re putting together a series of original takes from our IDDI Task force, here's the first thread🧵
It is with great sadness, we announce the tragic loss of one of the PVRI community's most beloved members, Professor Sheila Glennis Haworth CBE on the morning of 23 October 2020.
Something new is coming to PVRI...introducing our new webinar series, PVRI 2023/24 Digital, launching November 2023. Learn more about the scientific programme, book onto upcoming webinars or watch recordings of missed webinars here:
#PulmonaryHypertension
We're proud to introduce our new logo & visual identity, described by members as vibrant, warm, and memorable. It builds on PVRI’s legacy while modernising key elements to bring our much-loved warm and caring nature to life. Learn more:
#NewLookSamePassion
1/11 It's
#WorldHeartDay
. Here' a piece our IDDI Task Force have been working on: 'A proposed approach to consider the evolution of nice classification of PH 2013 - 2021' - a thread 👇🧵
We've hit another milestone on the Pulmonary Hypertension Global Patient Survey - over 2,000 responses across 68 countries! Thank you for your ongoing support in sharing the message. Find out how you can help here:
#PHGPS
#PulmonaryHypertension
Exciting news! With a record number of abstract submissions, our
#PVRI2024
Annual Congress in London is set to be one of our best yet. Don't miss out. Learn more and register here:
#PulmonaryHypertension
Today is
#WorldPHDay
. Here's a piece our IDDI Task Force have been working on: 'Inhaled Treprostinil in Pulmonary Hypertension Associated with Interstitial Lung Disease: Hope on the Horizon' - a thread🧵👇
We are delighted to be hosting a Women in PH Luncheon at our
#PVRI2024
Annual Congress in London. The Luncheon, sponsored by UTC, aims to foster engaging discussions with a focus on the career, academic advancement, and challenges faced by women working within the field of PVD.
Introducing the virtual symposium series by the iPVD Task Force. The first session of 'Inflammation series - the endothelium', will take place on 25 January at 4PM GMT date. You can register and find out more here:
The Burke Advanced Fellowship in Pulmonary Heart Disease at The Brigham and Women’s Hospital and Harvard Medical School invites applications for an advanced fellowship in pulmonary heart disease starting July 1, 2024. Learn more:
Tomorrow is
#WorldPHDay
. World Pulmonary Hypertension Day takes place every year on 5 May, with the aim of raising global awareness of this deadly disease.
Find out more on how we will be adding value to the conversation this year:
We are thrilled to welcome Dr Luke Howard
@HelpMyBreathing
to the IDDI leadership team! As he takes the reins from Dr
@mark_toshner
, we extend heartfelt gratitude for Mark's outstanding leadership. Here's to new beginnings and continued success in advancing our mission
Over the last few weeks, our 'Access to care' work stream have been working on getting help to PAH patients suffering from drug supply disruptions as a result of the conflict in Ukraine
A huge thank you to
@LucillaPiccari
, Brian Allwood, Katerina Antoniou, Jonathan H. Chung, Paul M. Hassoun, Sylvia M. Nikkho, Rajan Saggar, Oksana A. Shlobin, Patrizio Vitulo, Steven D. Nathan and Stephen John Wort for your work on this paper
🚨📯New paper: Pathogenesis & Phenotypes of
#PulmonaryHypertension
in
#InterstitialLungDisease
: a consensus statement from the
@PVRI
Innovative Drug Development Initiative - Group 3 PH
(Almost took a whole tweet to write!😅)
🌐
Highlights in thread 🧵👇1/n
Meet our keynotes: with just over two months to go until our
#PVRI2024
Annual Congress in London,
we're delighted to introduce our esteemed keynote speakers. Read the full programme and register here:
#PulmonaryHypertension
Welcome to all those attending our Annual World Congress on PVD in Lima. Professionals arrived from 39 countries to represent their labs and clinics here. Bienvenido!
#PVRI2020
PVRI2022 Athens is just 5 months away - we're looking forward to seeing some familiar faces again. Meet our first featured speaker, Allan Lawrie. More about Allan and his presentation here:
We are delighted to announce that the
#PHGPS
is now available in 7 additional languages: Bulgarian, Greek, Hebrew, Hungarian, Japanese, Latvian, and Romanian. Please continue to share the survey with your network in these regions:
We are proud to share with you the Bel Air Centre, a premier virtual conference space for
#pulmonaryhypertension
patients and stakeholders, developed by
@EuropePHA
. Join Marc Humbert at the grand opening on 29 Feb, 4pm CET. Register here
Register now for 'Clinical trials for pulmonary arterial hypertension: what are we learning?', the next webinar in our
#PVRIDigital
series. Our five highly respected speakers will be discussing all things clinical trials for
#PulmonaryArterialHypertension
:
Good news.. we are now accepting abstract submissions for our PVRI Annual Congress in London, Jan 2024. Full submissions guidelines and deadlines can be found here:
#PVRI2024
#Abstracts
#PulmonaryHypertension
Anna Hemnes, MD, professor of Medicine, has been named director of the Division of Allergy, Pulmonary and Critical Care Medicine, physician-in-chief of
@VUMCLung
and director of the Center for Lung Research.
Missed it? A replay of our latest PH Community Call is now available. In this call our expert hosts were joined by a panel of guest authors to discuss the latest developments in
#PulmonaryHypertension
this month. Watch now:
1/16 Second thread 🧵💪 to celebrate
#pulmonaryhypertension
awareness month - ‘Evolving technology for monitoring and measuring physical activity via accelerometry in patients with pulmonary hypertension’
We're looking forward to hosting you on our community call this Thursday at 3PM BST, with
@AlbertaPHdoc
, our PVRI social champions and guest
@mark_toshner
Our Pulmonary Hypertension Global Patient Survey
#PHGPS
has reached another milestone with 3,000+ responses from 78 countries! We are grateful for your continued support in spreading awareness. Discover ways to contribute here:
#PulmonaryHypertension
We are thrilled to announce that the Annual Drug Discovery and Development Symposium is back this year and will take place on 10-11 July 2023 in Bethesda, Maryland, USA.
Hanan Yusuf Ahmed, winner of the Butrous Foundation Award presents on screening patients with schistosomiasis associated hepatosplenic disease for PH in Ethiopia & Zambia - congratulations Hanan!
#PVRI2024
@AKirillova0424
, the winner of the 2024 Rupert Swift Award is up now, presenting on the reversal of inflammatory reprogramming at single cell resolution by vasodilator agents in PAH.
What's happening at PVRI's 2024 Annual Congress London? Explore the renowned speakers, cutting edge science and networking opportunities in the preliminary programme:
#PVRI2024
#PulmonaryHypertension
Congratulations to
@wli225
being awarded the best basic science abstract
#PVRI2022
for her beautiful work on the interaction of BMPR2 with BMP10. Important to improve mechanistic understanding of
#pah
. I love how BMP10/BMPR2 dance together
We are thrilled to announce the Pulmonary Hypertension Global Patient Survey
#PHGPS
is now live in 17 languages! Learn more and find out how you can help spread the word here:
The
#DDDS23
ended with a roundtable discussion led by
@mark_toshner
, Sylvia Nikkho, Ray Benza and Peter Fernandes. It had great audience participation and culminated in agreement on 3 challenges in drug development for the IDDI to focus on:
Our IDDI Group 3 PH Workstream have recently published a consensus statement on ‘Pulmonary hypertension in interstitial lung disease: Clinical trial design and endpoints’ 🧵👇
A recording of our world PH day webinar with keynote speaker Dr Martine Rothblatt and Professors Werner Seeger and Sir Magdi Yacoub is now available to watch for free on our website:
#PulmonaryHypertension
#LungTransplants
#WorldPHDay